Replies to post #11102 on GT Biopharma Inc (GTBP)

[mta65]

There is a window of opportunity for increased share value (basically trading pre-split in 2 to 3 cent range) and it must be balanced. I respect your numerical ability (your posts are telling) and I have come close to your dilution calculation (I've rummaged through the SEC filings - not the clearest but that will need to change if they get to NASDAQ) but differ with you when the value diminishes to under $1 (only likely to occur if fraud or acquisition unwinds). There is a balance of time with the current market of approximately 500K shares and the new dilution shares to get rid of disclosed debt and settlements that we can't miss (assuming all company disclosures are true and not misleading). Still remain optimistic timing wise with the big names, technology, and low float. This is a timing bet and effective management is needed to make it work or all parties lose. I'm in for the biotech advancements. That's my bottom line.